1-7 of 7
John M. Pagel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making

Thomas D. Brown, Paul D. Tittel, Philip J. Gold, Charles W. Drescher, John M. Pagel, J D. Beatty, Patra Grevstad, Desiree Iriarte, Shlece Alexander, Madeleine Brindle, Xiaoyu Liu, Donielle O'connor, Mariko Tameishi, Danbin Xu, Anna B. Berry
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 997.
https://doi.org/10.1158/1538-7445.AM2017-997
Published: 01 July 2017
View article titled, Abstract 997: Impact of a personalized medicine research program (PMRP), using targeted tumor profiling and a cloud based clinical trials matching platform, on clinical decision-making
Journal Articles

In Vivo Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model

Ethan R. Balkin, Aimee Kenoyer, Johnnie J. Orozco, Alexandra Hernandez, Mazyar Shadman, Darrell R. Fisher, Damian J. Green, Mark D. Hylarides, Oliver W. Press, D. Scott Wilbur, John M. Pagel
Journal: Cancer Research
Cancer Res (2014) 74 (20): 5846–5854.
https://doi.org/10.1158/0008-5472.CAN-14-0764
Published: 14 October 2014
View article titled, <em>In Vivo</em> Localization of <sup>90</sup>Y and <sup>177</sup>Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model
Open the PDF for <em>In Vivo</em> Localization of <sup>90</sup>Y and <sup>177</sup>Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model in another window
Includes: Supplementary data
Journal Articles

A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies

Damian J. Green, Nural N. Orgun, Jon C. Jones, Mark D. Hylarides, John M. Pagel, Donald K. Hamlin, D.S. Wilbur, Yukang Lin, Darrell R. Fisher, Aimee L. Kenoyer, Shani L. Frayo, Ajay K. Gopal, Johnnie J. Orozco, Theodore A. Gooley, Brent L. Wood, William I. Bensinger, Oliver W. Press
Journal: Cancer Research
Cancer Res (2014) 74 (4): 1179–1189.
https://doi.org/10.1158/0008-5472.CAN-13-1589
Published: 16 February 2014
View article titled, A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies
Open the PDF for A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies in another window
Includes: Supplementary data
Journal Articles

Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211

Hirohisa Nakamae, D. Scott Wilbur, Donald K. Hamlin, Monica S. Thakar, Erlinda B. Santos, Darrell R. Fisher, Aimee L. Kenoyer, John M. Pagel, Oliver W. Press, Rainer Storb, Brenda M. Sandmaier
Journal: Cancer Research
Cancer Res (2009) 69 (6): 2408–2415.
https://doi.org/10.1158/0008-5472.CAN-08-4363
Published: 17 March 2009
View article titled, Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
Open the PDF for Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211 in another window
Includes: Supplementary data
Journal Articles

Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia

John M. Pagel, Dana C. Matthews, Aimee Kenoyer, Donald K. Hamlin, Daniel S. Wilbur, Darrell R. Fisher, Ajay K. Gopal, Yukang Lin, Laura Saganic, Frederick R. Appelbaum, Oliver W. Press
Journal: Cancer Research
Cancer Res (2009) 69 (1): 185–192.
https://doi.org/10.1158/0008-5472.CAN-08-2513
Published: 31 December 2008
View article titled, Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia
Open the PDF for Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia in another window
Journal Articles

Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas

John M. Pagel, Anastasia Pantelias, Nathan Hedin, Shani Wilbur, Laura Saganic, Yukang Lin, Donald Axworthy, Donald K. Hamlin, D. Scott Wilbur, Ajay K. Gopal, Oliver W. Press
Journal: Cancer Research
Cancer Res (2007) 67 (12): 5921–5928.
https://doi.org/10.1158/0008-5472.CAN-07-0080
Published: 15 June 2007
View article titled, Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas
Open the PDF for Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas in another window
Journal Articles

A Genetically Engineered Anti-CD45 Single-Chain Antibody-Streptavidin Fusion Protein for Pretargeted Radioimmunotherapy of Hematologic Malignancies

Yukang Lin, John M. Pagel, Donald Axworthy, Anastasia Pantelias, Nathan Hedin, Oliver W. Press
Journal: Cancer Research
Cancer Res (2006) 66 (7): 3884–3892.
https://doi.org/10.1158/0008-5472.CAN-05-3443
Published: 03 April 2006
View article titled, A Genetically Engineered Anti-CD45 Single-Chain Antibody-Streptavidin Fusion Protein for Pretargeted Radioimmunotherapy of Hematologic Malignancies
Open the PDF for A Genetically Engineered Anti-CD45 Single-Chain Antibody-Streptavidin Fusion Protein for Pretargeted Radioimmunotherapy of Hematologic Malignancies in another window